Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antitubercular Treatment in Recurrent Anterior Uveitis (URBA)
NCT04117698Phase 3Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2019
- Primary completion
- May 2023
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of rifampicin, ethambutol, isoniazid + rifampicin in anterior uveitis (AU), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
rifampicinethambutolisoniazid + rifampicin
03
Conditions
anterior uveitis (AU)
Beyond the preview
Go deeper on NCT04117698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04117698.